23 March 2025 : Clinical Research
Intraoperative Renal Near-Infrared Spectroscopy Monitoring as a Predictor of Renal Outcomes in Cardiac Surgery
Buket Özyaprak
ABCDEFG 1*, Yılmaz Apaydın ABC 1, Şule Balk BCD 2, Mehmet Gamlı CDE 1, Abdulkadir İskender DEF 3, Gürcan Güler EFG 1, Damla Bozan Güler ABC 1, Ayşe Neslihan Balkaya BCD 1, Tuğba Onur CDEF 1, Canan Yılmaz DEF 1, Ümran Karaca EFG 1, Filiz Ata AFG 1, Yusuf Ata BCD 4, Gönül Erkan CEF 5, Nail Kahraman DFG 6
DOI: 10.12659/MSM.947462
Med Sci Monit 2025; 31:e947462
Table 2 Comparison of intraoperative parameters between patients with and without acute renal failure.
| Without ARF=Group 1 (n= 313) | With ARF=Group 2 (n= 44) | P value | |
|---|---|---|---|
| Operation duration (minutes), (mean±SD);median (min–max) | 217.3±24.38212 (180–360) | 226.0±19.1225 (190–270) | a |
| CPB duration (minutes), (mean±SD);median (min–max) | 102.6±12.0799 (84–165) | 111.9±19.6104.5 (91–175) | a |
| ACC Duration (minutes), (mean±SD);median (min–max) | 79.5±9.1476 (70–125) | 85.3±13.585 (70–125) | a |
| IABP n (%) | 3 (1.0%) | 3 (6.8%) | c |
| Erythrocyte suspension (units), median (min–max) | 1 (0–6) | 4 (0–8) | a |
| FFP (Units), median (min–max) | 2 (1–8) | 3.5 (2–5) | a |
| Inotropic agent therapy | |||
| 0 Inotrope infusion therapy n (%) | 15 (4.8%) | 2 (4.5%) | 1.000c |
| 1 Inotrope infusion therapy n (%) | 220 (70.3%) | 26 (59.1%) | 0.184b |
| 2 Inotrope infusion therapy n (%) | 61 (19.5%) | 7 (15.9%) | 0.718b |
| 3 Inotrope infusion therapy n (%) | 12 (3.83%) | 5 (11.36%) | c |
| 4 Inotrope infusion therapy n (%) | 5 (1.6%) | 4 (9.09%) | c |
| a Mann-Whitney U test; b Yates’s chi-square test; c Fisher’s chi-square test. SD – standard deviation; n – number; | |||